Conmed (CNMD) Tops Q4 EPS by 8c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
CONMED Corporation Announces Fourth Quarter and Full-Year 2020 Financial Results
January 27, 2021 4:05 PM ESTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020.
Fourth Quarter 2020 Highlights
Sales of $252.8 million decreased 4.5% year over year as reported and 5.2% in constant currency. Domestic revenue decreased 0.7% year over year. International revenue decreased 9.1% as reported year over year and 10.5% in constant currency. Diluted net earnings per share (GAAP) were $0.81, compared to diluted net earnings per share of $0.49 in the fourth quarter of 2019. Adjusted diluted net earnings per share(1) were $0.84 versus adjusted diluted... More